IDO1 and neoplasm: Regardless of IDO-mediated reduction in growth rate, tumor cells could benefit from IDO-mediated G1 arrest in the context of cytotoxic therapy; slowed cell cycle transit time can increase the amount and fidelity of DNA repair contributing to treatment resistance [46].